Given that DR5 expression was shown to be regulated by the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway[12], we next investigated the role of NF-κB pathway in regulating DR5 expression in the four glioblastoma cell lines. This evidence concerns the gene TNFRSF10B and glioblastoma.